Cite
APA Citation
Hagen, P., D'Souza, A., Hari, P., Davila, O., Zhang, M., Vesole, D. H., Smith, S. E., Rodriguez, T. E., & Stiff, P. J. (2020). busulfan, melphalan, and bortezomib compared to melphalan as a high dose regimen for autologous hematopoietic stem cell transplantation in multiple myeloma: long term follow up of a novel high dose regimen. Leukemia & lymphoma, 61(14), 3484–3492. http://access.bl.uk/ark:/81055/vdc_100120601411.0x000038